Security key
22053A107
Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX)
CUSIP: 22053A107
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 9,314,202
- Total 13F value
- $12,384,077
- Share change
- -2,310,500
- Put/Call ratio
- 55%
- SEC-reported price per share
- $1.33
- Number of holders
- 51
- Value change
- -$3,927,969
- Number of buys
- 18
- Number of sells
- 39
- Shares outstanding
- 60,216,782
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
51
Top holders
10
QNCX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Quince Therapeutics, Inc. SEC filings
Quince Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22053A107
Recent filing periods:
Ownership snapshot
Top reported holders of QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EPIQ Capital Group, LLC
Disclosed value leader
EPIQ Capital Group, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 5.4%
Showing 1-6 of 15 holder rows.
Quick read
EPIQ Capital Group, LLC leads the comparable SEC ownership view at 5.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EPIQ Capital Group, LLC's linked filing trail.
Comparable ownership
Top 5
EPIQ Capital Group, LLC
5.4%
VANGUARD GROUP INC
1.3%
JPMORGAN CHASE & CO
0.94%
MORGAN STANLEY
0.89%
FEDERATED HERMES, INC.
0.88%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EPIQ Capital Group, LLC |
13F
Company
|
5.4%
|
$7,272,000
3,275,548 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
1.3%
|
$1,750,000
787,988 shares
|
— | 30 Jun 2022 |
| JPMORGAN CHASE & CO |
13F
Company
|
0.94%
|
$1,259,000
567,047 shares
|
— | 30 Jun 2022 |
| MORGAN STANLEY |
13F
Company
|
0.89%
|
$1,188,000
534,671 shares
|
— | 30 Jun 2022 |
| FEDERATED HERMES, INC. |
13F
Company
|
0.88%
|
$1,173,000
528,564 shares
|
— | 30 Jun 2022 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
0.85%
|
$1,134,000
510,700 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
51
Shares
9,314,202
Rows available
51
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
60
Q3 2022 holders
51
Holder diff
-9
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend